RESTON, Va., Nov. 2, 2007 (PRIME NEWSWIRE) -- TenthGate International, Inc. (Pink Sheets:TGTI) ("TenthGate") www.tenthgate.biz, an innovative medical holding company focusing on healthcare-related, life-changing technologies, provides a follow-up summary report of its first shareholder conference call and quarterly board meeting discussions held on October 15th and 16th, 2007, respectively. All six directors were present for the board meeting.
Major discussion points:
* Finalization of the July 31st fiscal year end audit engaged with Kingery & Crouse, PA for TenthGate International, Inc. and all company subsidiaries. Resulting financial statements to be disclosed in public domain upon completion. * Formal communications to be sent by November 20, 2007 related to TenthGate's melanoma technologies as a result of the FDA's recent call for comment on their updated sunscreen guidelines. * Strategic partnering initiatives associated with the development and commercialization of the initial Melanocyte Protective Factor (MPF(tm)) technology application. * December 1, 2007 retail sales launch date set of the FDA approved Ice Baton(r) product and company general revenue development activities. * Business development discussions of additional targeted life-changing technologies.
The TenthGate International, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3179
Safe Harbor Disclaimer
Except for the historical information contained herein, the matters discussed in this press release may include forward-looking statements or information. All statements, other than statements of historical fact, including, without limitation, those with respect to the objectives, plans and strategies of TenthGate International, Inc., and its affiliates, set forth herein and those preceded by or that include the words "believes," "expects," "given," "targets," "intends," "anticipates," "plans," "projects", "forecasts" or similar expressions, are forward-looking statements. Although the Company's management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct. These forward-looking statements involve a number of risks and uncertainties which could cause the Company's future results to differ materially from those anticipated. The Company assumes no obligation to update any of the information contained or referenced in this press release.